Acute and chronic angiotensin-(1-7) restores vasodilation and reduces oxidative stress in mesenteric arteries of salt-fed rats.
Gábor Raffai, Matthew J Durand, Julian H Lombard
Index: Am. J. Physiol. Heart Circ. Physiol. 301(4) , H1341-52, (2011)
Full Text: HTML
Abstract
This study determined the effect of ANG-(1-7) on salt-induced suppression of endothelium-dependent vasodilatation in the mesenteric arteries of male Sprague-Dawley rats. Chronic intravenous infusion of ANG-(1-7), oral administration of the nonpeptide mas receptor agonist AVE-0991, and acute preincubation of the arteries with ANG-(1-7) and AVE-0991 all restored vasodilator responses to both ACh and histamine that were absent in the arteries of rats fed a high-salt (4% NaCl) diet. The protective effects of ANG-(1-7) and AVE-0991 were inhibited by acute or chronic administration of the mas receptor antagonist A-779, the ANG II type 2 (AT(2)) receptor blocker PD-123319, or N-nitro-l-arginine methyl ester, but not the ANG II type 1 receptor antagonist losartan. Preincubation with the antioxidant tempol or the nitric oxide (NO) donor diethylenetriamine NONOate and acute and chronic administration of the AT(2) receptor agonist CGP-42112 mimicked the protective effect of ANG-(1-7) to restore vascular relaxation. Acute preincubation with ANG-(1-7) and chronic infusion of ANG-(1-7) ameliorated the elevated superoxide levels in rats fed a high-salt diet, but the expression of Cu/Zn SOD and Mn SOD enzyme proteins in the vessel wall was unaffected by ANG-(1-7) infusion. These results indicate that both acute and chronic systemic administration of ANG-(1-7) or AVE-0991 restore endothelium-dependent vascular relaxation in salt-fed Sprague-Dawley rats by reducing vascular oxidant stress and enhancing NO availability via mas and AT(2) receptors. These findings suggest a therapeutic potential for mas/AT(2) receptor activation in preventing the vascular oxidant stress and endothelial dysfunction associated with elevated dietary salt intake.
Related Compounds
Related Articles:
Altered efficacy of AT1R-targeted treatment after spontaneous cancer cell-AT1R upregulation.
2011-01-01
[BMC Cancer 11 , 274, (2011)]
Update on the angiotensin AT(2) receptor.
2013-02-01
[Curr. Hypertens. Rep. 15(1) , 25-30, (2013)]
Angiotensin III modulates the nociceptive control mediated by the periaqueductal gray matter
2009-12-15
[Neuroscience 164(3) , 1263-73, (2009)]
2009-03-01
[Am. J. Physiol. Heart Circ. Physiol. 296(3) , H745-55, (2009)]
2007-10-01
[J. Cardiovasc. Pharmacol. 50(4) , 372-9, (2007)]